XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Note 3 - Collaborative Arrangements and Contracts With Customers (Details Textual)
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Accounts Receivable, after Allowance for Credit Loss, Current $ 463,834   $ 463,834   $ 277,641
Accounts Receivable, Allowance for Credit Loss, Current 0   0   0
Contract with Customer, Liability 267,439   267,439   $ 307,958
Contract with Customer, Liability, Revenue Recognized $ 7,643   $ 68,188    
Revenue Benchmark [Member] | Customer Concentration Risk [Member]          
Number of Customers 2 1 1 1  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]          
Concentration Risk, Percentage 28.00%        
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]          
Concentration Risk, Percentage 22.00%        
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Single Customer [Member]          
Concentration Risk, Percentage   62.00% 33.00% 34.00%  
Cancer Research Horizons [Member] | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]          
Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer     $ 0 $ 0